Immuno-Oncology: NEC Bio B.V.

About this session

NEC Bio is a biotechnology company headquartered in the Netherlands, advancing AI powered immunotherapy platforms for oncology, biologics optimization, and infectious diseases. As part of the NEC Group, the company integrates advanced AI based computational immunology, antigen prediction, and structural modeling to design therapies that improve immune targeting, durability, and clinical performance.

Speaker

• HL

  Heinz Lubenau

  CEO · NEC Bio B.V.

  Speaker